BASEL, Switzerland, April 9, 2014 (GLOBE NEWSWIRE) -- Basilea Pharmaceutica Ltd. (SIX: BSLN) reported that at today’s Ordinary General Meeting of Shareholders for the financial year 2013, shareholders approved all agenda items proposed by the Board of Directors. At the meeting, 51.3 percent of Basilea’s share capital was represented.
Help employers find you! Check out all the jobs and post your resume.